BI 706321 / Boehringer Ingelheim  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
BI 706321 / Boehringer Ingelheim
NCT04978493 / 2020-004527-16: A Study to Test Whether BI 706321 Combined With Ustekinumab Helps People With Crohn's Disease

Active, not recruiting
2
49
Europe, US, RoW
BI 706321, ustekinumab, Placebo
Boehringer Ingelheim, Boehringer Ingelheim International GmbH
Crohn Disease
07/24
03/25

Download Options